ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1372	National Cancer Institute	Html	en	Prostate Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for prostate cancer.	stage prostate cancer 0.41534 prostate cancer families 0.421963 Prostate cancer histologic 0.416191 prostate cancer death 0.461069 prostate cancer-specific mortality 0.450231 prostate cancer detection 0.469664 occult prostate cancer 0.443862 cumulative prostate cancer 0.443087 Prostate Cancer Prostatic 0.422226 clinically localized prostate 0.413378 prostate cancer incidence 0.469487 prostate cancer risk 0.463531 prostate specific antigen 0.460602 Natl Cancer Inst 0.507286 prostate cancer conundrum 0.415161 organ-confined prostate cancer 0.420237 Prostate Cancer Prevention 0.415424 prostate cancers 0.438581 incidental prostate cancer 0.422784 prostate cancer incidents 0.441917 age-adjusted prostate cancer 0.427473 National Prostate Cancer 0.437284 prostate biopsy 0.439547 prostate cancer deaths 0.439576 Prostate Cancer Group 0.440788	recent prostate cancer 0.414693 Localized Prostate Cancer 0.420799 prostate cancer mortality 0.720857 background prostate cancer 0.428331 Cancer Society-National Prostate 0.419744 prostate cancer cases 0.433809 early prostate cancer 0.423859 increase prostate cancer 0.419618 prostate cancer susceptibility 0.420924 Prostate Cancer Treatment 0.436062 decreases prostate cancer 0.418061 prostate cancer diagnosis. 0.428017 Abstract 0.431496 Prostate Cancer Register 0.417403 prostate cancer survival 0.421804 prostate cancer diagnosis 0.475983 prostate cancer screening 0.57009 prostate cancer 0.946722 Finnish prostate cancer 0.414198 low-risk prostate cancer 0.432239 prostate cancer death. 0.426919 Population-based Prostate Cancer 0.418712 early-stage prostate cancer 0.444191 prostate cancer recurrence 0.415556	CLICK HERE
1462	National Cancer Institute	Html	en	Gastrointestinal Carcinoid Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of gastrointestinal carcinoid tumors.	low-grade neuroendocrine tumors 0.396019 duodenal carcinoid tumor 0.397268 multifocal neuroendocrine tumors 0.421413 carcinoid patients 0.422833 relatively common carcinoids 0.388053 midgut neuroendocrine tumors 0.400819 midgut carcinoids 0.398106 carcinoid neuroendocrine tumors 0.530837 carcinoid heart failure. 0.412799 midgut carcinoid syndrome 0.494495 tract carcinoid tumors 0.466207 sporadic neuroendocrine tumors 0.41799 carcinoid heart disease 0.604399 multiple carcinoid tumors 0.498345 patients 0.441078 Pract Res Clin 0.384377 gastric carcinoids 0.406312 carcinoid symptoms 0.386144 Malignant carcinoid tumors 0.458841 ileal carcinoids 0.443228 carcinoid tumors 0.921678 Carcinoid Tumors section 0.552577 Gastrointestinal carcinoids 0.396139 term carcinoid 0.38666 gut neuroendocrine tumors 0.405828	gastric argyrophil carcinoid 0.39372 neuroendocrine tumors 0.772231 et al. 0.477186 carcinoid syndrome. 0.396106 renal carcinoid tumor 0.400621 rectal carcinoids 0.465534 Gastrointestinal Carcinoid Tumors 0.556816 rectal carcinoid patients 0.421651 carcinoids 0.607075 PUBMED Abstract 0.470567 multiple endocrine neoplasia 0.391617 frequent carcinoid tumor 0.405695 5-year survival 0.39049 neuroendocrine tumours 0.472335 neuroendocrine gastrointestinal tumors 0.422781 Pancreatic Neuroendocrine Tumors 0.446589 well-differentiated neuroendocrine tumors 0.443559 Abstract 0.585558 gastrointestinal carcinoid tumor 0.427766 carcinoid syndrome 0.595242 severe carcinoid heart 0.411522 gastroenteropancreatic neuroendocrine tumors 0.419971 metastatic carcinoid tumors 0.588139 duodenal carcinoids 0.494906	CLICK HERE
1646	National Cancer Institute	Html	en	Cancer Screening Overview (PDQ®)–Patient Version	Information about measuring the effectiveness of cancer screening tests and about weighing the strength of the evidence obtained from cancer screening research studies.	new screening test 0.617185 health care provider 0.670679 odds ratio 0.601994 PDQ cancer information 0.657991 clinical trials 0.728892 cervical cancer rates 0.56941 test result 0.575182 cancer information summary 0.627344 group 0.594884 clinical trial 0.572791 test results 0.625142 breast cancer prevention 0.567805 cancer patients 0.585953 PDQ® Screening 0.567153 cancer risk factor 0.586088 cervical cancer 0.569926 relative risk 0.572167 symptoms 0.56993 cancer symptoms 0.5675 NCI PDQ cancer 0.589008 accurate cancer screening 0.616077 useful cancer screening 0.649307 PDQ Screening 0.5802 Cancer Information Service 0.580898	useful screening test 0.597804 Prevention Editorial Board 0.577411 certain disease 0.568589 National Cancer Institute 0.720252 studies 0.621784 certain gene mutations 0.593801 Screening trials 0.573937 Cancer Care page 0.570337 breast cancer 0.60178 people 0.685308 absolute risk 0.574938 standard screening test 0.598763 survival time 0.567302 screening test 0.737252 cancer screening tests 0.703056 cancer information summaries 0.578991 screening procedures 0.580721 comprehensive cancer information 0.579656 long cancer patients 0.576239 screening mammogram 0.574868 cancer 0.928642 information 0.71123 risk 0.62101 research studies 0.609116	CLICK HERE
1899	National Cancer Institute	Html	es	Tratamiento del cáncer de esófago (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer de esófago.	pequeñas incisiones 0.23384 siguientes procedimientos 0.284377 estadio iv 0.901829 siguientes aspectos 0.246993 cirugía.ampliar cáncer 0.384736 tumor.ampliar cáncer 0.927954 esófago.ampliar cáncer 0.406819 superior.ampliar ingesta 0.240636 rayos x 0.233574 estadio ib 0.846212 estadio ia 0.848718 enlace drugs approved 0.225674 cuerpo.ampliar adenocarcinoma 0.237712 ondas sonoras 0.23487 tumor.ampliar adenocarcinoma 0.237933 carcinoma epidermoide 0.253815 National Cancer Institute 0.207996 oampliar adenocarcinoma 0.284398	Instituto Nacional 0.217897 estadio iiia 0.772409 PDQ Tratamiento 0.210664 estadio iiic 0.728279 raras ocasiones 0.236561 estadio iiib 0.520728 estadio iia 0.995304 estadio iib 0.810094 Physician Data Query 0.236785 haz angosto 0.214315 pequeña incisión 0.215302 cirugía.ampliar adenocarcinoma 0.240417 Esophageal Cancer 0.21336 crecimiento her2 0.212549 3.ampliar adenocarcinoma 0.246955 cuerpo.ampliar cáncer 0.373348 siguientes pruebas 0.298459	CLICK HERE
1984	National Cancer Institute	Html	es	Cuidados médicos de apoyo en niños (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de la peculiaridad de los asuntos que surgen durante y después del tratamiento en los niños con cáncer y como sobrevivientes adultos de cáncer.	among adult survivors 0.308012 Dev Behav Pediatr 0.311435 Last BF 0.307728 randomized controlled trials 0.307154 childhood cancer survivors 0.686811 Arch Gen Psychiatry 0.307642 largo plazo 0.386463 American Cancer Society 0.324849 Child Adolesc Psychiatry 0.308067 posttraumatic stress symptoms 0.324331 health-related quality 0.319663 Child Health Care 0.307161 adult survivors 0.332882 Hobbie WL 0.307769 suicidal ideation 0.309111 Pediatr Psychol 0.406392 stress symptoms during 0.307126 Health Care 0.307239 Grootenhuis MA 0.307795 Pediatr Nurs 0.308601 childhood cancer 0.948281 cancer survivor study 0.418789 células madre 0.316714 young adult survivors 0.314912 Phipps S 0.31239	adultos jóvenes 0.324674 Cancer Suppl 0.320779 Children’s Oncology Group 0.311705 leucemia linfoblástica aguda 0.307137 Cancer Facts 0.31467 posttraumatic stress 0.424392 Pediatr Blood Cancer 0.341708 sobrevivientes adultos 0.315742 efectos tardíos 0.308299 report from 0.327686 childhood leukemia 0.320175 during treatment 0.3081 Pediatr Oncol Nurs 0.312201 children with 0.442277 bone marrow transplant 0.30728 Pediatr Oncol 0.312328 Pediatr Hematol Oncol 0.312789 Clin Oncol 0.319255 sistema nervioso central 0.312739 tensión traumática 0.309229 Zebrack BJ 0.312471 surviving childhood 0.31989 Gartstein MA 0.308683 Zeltzer LK 0.312906	CLICK HERE
15713	National Cancer Institute	Html	es	Desigualdades por cáncer	Información básica de las desigualdades por cáncer en EE. UU., factores que contribuyen a la carga desproporcionada del cáncer en algunos grupos y ejemplos de desigualdades en incidencia y mortalidad entre ciertos grupos de la población.	excesivo consumo 0.503273 enfermedad llamada 0.433789	Estados Unidos 0.991629	CLICK HERE
16381	National Cancer Institute	Html	es	Características genómicas de los cánceres infantiles (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las características genómicas de los cánceres infantiles. En este sumario se describen los subtipos moleculares de tipos específicos de cáncer infantil y las características clínicas relacionadas, las alteraciones genómicas recurrentes que caracterizan cada subtipo en el momento del diagnóstico o recidiva, y la importancia terapéutica y pronóstica de estas alteraciones. Se tratan las alteraciones genómicas relacionadas con tumores de encéfalo, tumores de riñón, leucemias, linfomas y otros tipos de cáncer.	frecuencia mutaciones 0.528888 genes mll 0.472072 Pediatric Acute Myeloid 0.497416 fusión npm-alk 0.439451 gen runx1t1 0.441044 North America 0.442782 IKZF1Las deleciones 0.453665 Sin embargo 0.617309 Katherine Tarlock 0.44723 mutaciones h3.3 0.551025 necesarias mutaciones 0.521725 secuencias codificadoras gfi1 0.437106 LLA hiperdiploide 0.80788 fusión il3-igh 0.467917 subtipo fab 0.455149 Ampliar Figura 0.451303 Pediatric Clinics 0.456212 Soheil Meshinchi 0.449095 gen etv6 0.449542 principales genes 0.447125 Otro gen 0.448963 GFI1 family oncogenes 0.435878 alteraciones genómicas tipo 0.497294 Genomic Variants 0.448917 gen mll 0.771285	células madre 0.513259 recaídas tardías 0.468538 leucemia linfoblástica aguda 0.548223 fusión bcr-abl1 0.481925 tipo ii 0.523537 gen runx1 0.541242 fusión etv6-runx1 0.484276 cromosoma filadelfia 0.948411 Acute Myeloid Leukemia 0.490135 valor pronóstico adverso 0.452162 Acute Lymphoblastic Leukemia 0.435296 células leucémicas hiperdiploides 0.488327 gen cbf-beta 0.443623 Age Group 0.442656 cromosomas hiperdiploidía 0.455258 Predisposition Genes 0.44826 fusión tcf3-hlf 0.515862 mutaciones activadoras 0.657624 Pediatric Oncology Group 0.437603 Therapeutic Implications 0.450243 genes jak 0.448326 Oncology Group 0.451583 subtipo fab m2 0.437855 determinados cánceres 0.434561	CLICK HERE
16696	National Cancer Institute	Html	en	Understanding Cervical Changes: A Health Guide for Women	Explains abnormal Pap test, HPV test, and Pap/HPV cotest results. Treatment and follow-up care for abnormal cervical cancer screening results including ASC-US, AGC, LSIL, ASC-H, HSIL, AIS. Learn about colposcopy, types of biopsies, CIN, and HPV vaccine.	cervical screening test 0.296143 cervical cancer cells 0.337703 health care provider 0.931179 cause cervical cancer 0.303315 abnormal cervical changes 0.298611 HPV types 0.331542 hpv infections 0.33479 abnormal cervical cell 0.295805 different HPV test 0.298266 cervical screening tests 0.300727 cervical cells 0.440061 HPV test work 0.298659 test results 0.460749 abnormal cervical screening 0.340129 HPV test 0.548179 cervical cancer screening 0.419584 HPV test result 0.334901 pap test 0.669223 cervical cancer 0.659605 abnormal test result 0.292044 high-risk hpv types 0.317446 HPV test results 0.312992 high-risk HPV infection 0.300301 women 0.2963	treatment 0.297209 abnormal cervical cells 0.352195 HPV vaccination 0.281435 Follow-Up Testing section 0.335149 HPV vaccine 0.303379 routine HPV testing 0.291048 HPV 0.555747 Pap test result 0.316098 Low-risk HPV types 0.299422 cervical cell changes 0.36625 Cervical screening recommendations 0.28727 abnormal pap test 0.394575 abnormal cervical cancer 0.33209 HPV vaccine series 0.282155 Normal Pap test 0.282878 Unsatisfactory Pap test 0.281328 Possible next steps 0.307487 common abnormal Pap 0.287706 HPV tests 0.293108 pap test results 0.389844 HPV infection 0.355986 abnormal cervical tissue 0.293862 recent abnormal Pap 0.289466 Cervical Cancer Treatment 0.291973	CLICK HERE
16835	National Cancer Institute	Html	en	Northwestern University — Cancer Nanotechnology Training Program	The focus of the Northwestern University Cancer Nanotechnology Training Center is presented here.	biological properties 0.685837 NU CCNE 0.813714 trainees 0.492664 Objectives 0.460665 cancer nanomaterials 0.715227 Ph.D 0.461621 tools 0.451616 basic courses 0.711616 research-based experiences 0.739642 skills 0.492332 career development programs 0.972187 MD 0.452108 PhD-level investigators 0.739449 centers 0.44872 National Cancer Institute 0.928332 Principal Investigator 0.787408 translational research 0.758394	clinical oncology 0.731649 International Institute 0.698015 needs 0.449442 Faculty 0.448884 Northwestern CNTC website 0.922154 Gayle Woloschak 0.790491 cancer patients 0.717775 eventual goal 0.748956 BioNanotechnology 0.51845 well-rounded curriculum 0.761183 efficacy 0.474176 nanotechnology resources 0.803175 principles 0.451682 Training Focus 0.735308 cancer biology 0.721666 training program 0.906256	CLICK HERE
17280	National Cancer Institute	Html	es	Preguntas para el doctor sobre el cáncer avanzado	Preguntas que pueden guiarle durante su charla con el doctor al hablar sobre sus opciones de atención para su cáncer avanzado y los pasos siguientes que debe dar.	¿Cuál tratamiento 0.93725		CLICK HERE